34 results
8-K
EX-99.1
ACGN
Aceragen Inc
14 Nov 22
Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:39pm
programs that we are developing to be innovative therapeutics capable of addressing the unmet medical needs of these individuals. To learn more about
DEFA14A
EX-99.1
uorsqrq rsql
28 Sep 22
Additional proxy soliciting materials
4:59pm
8-K
EX-99.1
xwxnp4vz69
28 Sep 22
Idera Pharmaceuticals Acquires Aceragen
4:29pm
8-K
EX-99.1
8sdd70b4
11 Jan 21
Idera Pharmaceuticals to Present at Upcoming Conferences
6:04am
8-K
EX-99.1
ql3322h
17 Nov 20
Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer
4:20pm
425
tqadzeyhl4 5i5v
21 Jun 18
Business combination disclosure
6:06am
425
5vat7seui6c hb
7 Jun 18
Business combination disclosure
8:17am